LORBRENA vs RAPAMUNE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. LORBRENA and RAPAMUNE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LORBRENA	RAPAMUNE
Rating	64/100	New
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	LORLATINIB	SIROLIMUS
Manufacturer	Pfizer	Pf Prism Cv
Dosage forms	Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	—	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

lorbrena rapamune

Rating

64/100

New

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

LORLATINIB

SIROLIMUS

Manufacturer

Pfizer

Pf Prism Cv

Dosage forms

Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

—

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Lorbrena and Rapamune?

Lorbrena contains Lorlatinib, while Rapamune contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.